Table 3.
IGF-2 and PHLDA2 levels between the two investigated groups
Variables | MCDA sIUGR patients (n=10) | Controls (n=10) | Z value | P value |
---|---|---|---|---|
IGF2, ng/ml | 30.18±4.70 | 54.52±16.28 | -4.328 | <0.01 |
PHLDA2, ng/ml | 1.06±0.31 | 0.95±0.63 | 0.727 | >0.05 |
IGF-2 and PHLDA2 levels between the two investigated groups
Variables | MCDA sIUGR patients (n=10) | Controls (n=10) | Z value | P value |
---|---|---|---|---|
IGF2, ng/ml | 30.18±4.70 | 54.52±16.28 | -4.328 | <0.01 |
PHLDA2, ng/ml | 1.06±0.31 | 0.95±0.63 | 0.727 | >0.05 |